<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="3108" OLDID="19523" TOPICS="NO">
<DATE> 9-MAR-1987 10:41:25.30</DATE>
<TOPICS/>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f0339 reute
r f BC-CIBA-GIEGY-IN-PACT-TO   03-09 0091</UNKNOWN>
<TEXT> 
<TITLE>CIBA-GIEGY IN PACT TO MAKE GALLSTONE DISSOLVER</TITLE>
<DATELINE>    SUMMIT, N.J., March 9 - </DATELINE><BODY>&lt;Ciba-Giegy Corp&gt;'s Ciba-Giegy 
Pharmaceuticals division said it had an agreement with
&lt;Gipharmex S.P.A.&gt; (Giuliani Group), of Milan, Italy, to
develop and eventually market in the U.S. a new gallstone
dissolving drug.
    The company said the drug, ursodeoxycholic acid, is a
naturally occurring bile acid and has been approved for
marketing in most European countries and in Japan.
    The division said it holds a patent on the use of the drug
to dissolve gallstones.
 Reuter
 </BODY></TEXT>
</REUTERS>